Literature DB >> 28601185

Emerging Therapeutic Potential Targeting Genetics and Epigentics in Heart Failure.

Jun Ren1, Yingmei Zhang2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28601185     DOI： 10.1016/j.bbadis.2017.05.023

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN： 0925-4439            Impact factor:   5.187


× No keyword cloud information.
  4 in total

1.  Self-emulsifying drug delivery system improves preventive effect of curcuminoids on chronic heart failure in rats.

Authors:  Yunbin Jiang; Junzhi Wang; Yunhong Wang; Xiumei Ke; Chuanhui Zhang; Rongping Yang
Journal:  Saudi Pharm J       Date:  2018-02-05       Impact factor: 4.330

2.  Prohibitin 2 deficiency impairs cardiac fatty acid oxidation and causes heart failure.

Authors:  Dechao Wu; Chongshu Jian; Qi Peng; Tingting Hou; Keling Wu; Bizhi Shang; Minglei Zhao; Yanru Wang; Wen Zheng; Qi Ma; Chuan-Yun Li; Heping Cheng; Xianhua Wang; Ling Zhao
Journal:  Cell Death Dis       Date:  2020-03-12       Impact factor: 8.469

Review 3.  Genetic Markers for Coronary Artery Disease.

Authors:  Nevena Veljkovic; Bozidarka Zaric; Ilona Djuric; Milan Obradovic; Emina Sudar-Milovanovic; Djordje Radak; Esma R Isenovic
Journal:  Medicina (Kaunas)       Date:  2018-05-28       Impact factor: 2.430

Review 4.  Mitochondrial Ca2+ regulation in the etiology of heart failure: physiological and pathophysiological implications.

Authors:  Hai-Xia Xu; Su-Mei Cui; Ying-Mei Zhang; Jun Ren
Journal:  Acta Pharmacol Sin       Date:  2020-07-21       Impact factor: 6.150
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.